Cargando…
Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
OBJECTIVE: This study was undertaken to validate the accuracy of the Epidemiology‐Based Mortality Score in Status Epilepticus (EMSE) in predicting the risk of death at 30 days in a large cohort of patients with status epilepticus (SE) using a machine learning system. METHODS: We included consecutive...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804228/ https://www.ncbi.nlm.nih.gov/pubmed/35869796 http://dx.doi.org/10.1111/epi.17372 |
_version_ | 1784862058518413312 |
---|---|
author | Brigo, Francesco Turcato, Gianni Lattanzi, Simona Orlandi, Niccolò Turchi, Giulia Zaboli, Arian Giovannini, Giada Meletti, Stefano |
author_facet | Brigo, Francesco Turcato, Gianni Lattanzi, Simona Orlandi, Niccolò Turchi, Giulia Zaboli, Arian Giovannini, Giada Meletti, Stefano |
author_sort | Brigo, Francesco |
collection | PubMed |
description | OBJECTIVE: This study was undertaken to validate the accuracy of the Epidemiology‐Based Mortality Score in Status Epilepticus (EMSE) in predicting the risk of death at 30 days in a large cohort of patients with status epilepticus (SE) using a machine learning system. METHODS: We included consecutive patients with SE admitted from 2013 to 2021 at Modena Academic Hospital. A decision tree analysis was performed using the 30‐day mortality as a dependent variable and the EMSE predictors as input variables. We evaluated the accuracy of EMSE in predicting 30‐day mortality using the area under the receiver operating characteristic curve (AUC ROC), with 95% confidence interval (CI). We performed a subgroup analysis on nonhypoxic SE. RESULTS: A total of 698 patients with SE were included, with a 30‐day mortality of 28.9% (202/698). The mean EMSE value in the entire population was 57.1 (SD = 36.3); it was lower in surviving compared to deceased patients (47.1, SD = 31.7 vs. 81.9, SD = 34.8; p < .001). The EMSE was accurate in predicting 30‐day mortality, with an AUC ROC of .782 (95% CI = .747–.816). Etiology was the most relevant predictor, followed by age, electroencephalogram (EEG), and EMSE comorbidity group B. The decision tree analysis using EMSE variables correctly predicted the risk of mortality in 77.9% of cases; the prediction was accurate in 85.7% of surviving and in 58.9% of deceased patients within 30 days after SE. In nonhypoxic SE, the most relevant predictor was age, followed by EEG, and EMSE comorbidity group B; the prediction was correct in 78.9% of all cases (89.6% in survivors and 46.1% in nonsurvivors). SIGNIFICANCE: This validation study using a machine learning analysis shows that the EMSE is a valuable prognostic tool, and appears particularly accurate and effective in identifying patients with 30‐day survival, whereas its performance in predicting 30‐day mortality is lower and needs to be further improved. |
format | Online Article Text |
id | pubmed-9804228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98042282023-01-03 Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus Brigo, Francesco Turcato, Gianni Lattanzi, Simona Orlandi, Niccolò Turchi, Giulia Zaboli, Arian Giovannini, Giada Meletti, Stefano Epilepsia Research Article OBJECTIVE: This study was undertaken to validate the accuracy of the Epidemiology‐Based Mortality Score in Status Epilepticus (EMSE) in predicting the risk of death at 30 days in a large cohort of patients with status epilepticus (SE) using a machine learning system. METHODS: We included consecutive patients with SE admitted from 2013 to 2021 at Modena Academic Hospital. A decision tree analysis was performed using the 30‐day mortality as a dependent variable and the EMSE predictors as input variables. We evaluated the accuracy of EMSE in predicting 30‐day mortality using the area under the receiver operating characteristic curve (AUC ROC), with 95% confidence interval (CI). We performed a subgroup analysis on nonhypoxic SE. RESULTS: A total of 698 patients with SE were included, with a 30‐day mortality of 28.9% (202/698). The mean EMSE value in the entire population was 57.1 (SD = 36.3); it was lower in surviving compared to deceased patients (47.1, SD = 31.7 vs. 81.9, SD = 34.8; p < .001). The EMSE was accurate in predicting 30‐day mortality, with an AUC ROC of .782 (95% CI = .747–.816). Etiology was the most relevant predictor, followed by age, electroencephalogram (EEG), and EMSE comorbidity group B. The decision tree analysis using EMSE variables correctly predicted the risk of mortality in 77.9% of cases; the prediction was accurate in 85.7% of surviving and in 58.9% of deceased patients within 30 days after SE. In nonhypoxic SE, the most relevant predictor was age, followed by EEG, and EMSE comorbidity group B; the prediction was correct in 78.9% of all cases (89.6% in survivors and 46.1% in nonsurvivors). SIGNIFICANCE: This validation study using a machine learning analysis shows that the EMSE is a valuable prognostic tool, and appears particularly accurate and effective in identifying patients with 30‐day survival, whereas its performance in predicting 30‐day mortality is lower and needs to be further improved. John Wiley and Sons Inc. 2022-08-23 2022-10 /pmc/articles/PMC9804228/ /pubmed/35869796 http://dx.doi.org/10.1111/epi.17372 Text en © 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Article Brigo, Francesco Turcato, Gianni Lattanzi, Simona Orlandi, Niccolò Turchi, Giulia Zaboli, Arian Giovannini, Giada Meletti, Stefano Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus |
title | Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus |
title_full | Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus |
title_fullStr | Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus |
title_full_unstemmed | Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus |
title_short | Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus |
title_sort | machine learning validation through decision tree analysis of the epidemiology‐based mortality score in status epilepticus |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804228/ https://www.ncbi.nlm.nih.gov/pubmed/35869796 http://dx.doi.org/10.1111/epi.17372 |
work_keys_str_mv | AT brigofrancesco machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus AT turcatogianni machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus AT lattanzisimona machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus AT orlandiniccolo machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus AT turchigiulia machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus AT zaboliarian machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus AT giovanninigiada machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus AT melettistefano machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus |